Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Future Oncology (London, England)
|
July 13, 2021
Immune checkpoint inhibitors plus anlotinib versus anlotinib alone as third-line treatment in advanced non-small-cell lung cancer: a retrospective study
Wenjie Zhang, Chufeng Zhang, Shengjie Yang, et al.
Molecular Diversity
|
February 8, 2018
Design, synthesis, and SAR study of highly potent, selective, irreversible covalent JAK3 inhibitors
Linhong He, Mingfeng Shao, Taijin Wang, et al.
Acta Oncologica (Stockholm, Sweden)
|
June 28, 2023
Tumor-infiltrating lymphocytes predict efficacy of immunotherapy in advanced non-small cell lung cancer: a single-center retrospective cohort study
Wenjie Zhang, Sumei Li, Chufeng Zhang, et al.
Advanced Biology
|
February 23, 2026
Feiwei Mixture Exerts Antitumor Activity Against Non-Small Cell Lung Cancer via Regulating NR1D1-Mediated Immune Cell Infiltration
Haiyong Wang, Lingsun Guo, Yu Zhao, et al.
Archiv Der Pharmazie
|
September 26, 2017
Design and Synthesis of a Highly Selective JAK3 Inhibitor for the Treatment of Rheumatoid Arthritis
Linhong He, Heying Pei, Tingxuan Lan, et al.
The Journal of Chemical Physics
|
April 8, 2025
Light-matter interaction at the nano- and molecular scale
Kaifeng Wu, Chufeng Zhang, Xinfeng Liu, et al.
Technology in Cancer Research & Treatment
|
May 8, 2015
Progress of Circulating Tumor Cells in Cancer Management
Chufeng Zhang, Lijie Wang, Yan Guan, et al.
Journal of Cancer Research and Clinical Oncology
|
January 27, 2024
Efficacy of immunotherapy in HER2-mutated non-small cell lung cancer: a single-arm meta-analysis
Juguang Zhang, Weizhong Han, Jun Guo, et al.
Oncology Letters
|
April 8, 2024
Efficacy and survival outcomes of alectinib vs. crizotinib in ALK‑positive NSCLC patients with CNS metastases: A retrospective study
Qing Liu, Ying Fu, Jun Guo, et al.
European Journal of Medicinal Chemistry
|
March 16, 2019
Design, synthesis and evaluation of novel 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as potent, selective and reversible Bruton's tyrosine kinase (BTK) inhibitors for the treatment of rheumatoid arthritis
Chufeng Zhang, Heying Pei, Jun He, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Future Oncology (London, England)
|
July 13, 2021
Immune checkpoint inhibitors plus anlotinib versus anlotinib alone as third-line treatment in advanced non-small-cell lung cancer: a retrospective study
Wenjie Zhang, Chufeng Zhang, Shengjie Yang, et al.
Molecular Diversity
|
February 8, 2018
Design, synthesis, and SAR study of highly potent, selective, irreversible covalent JAK3 inhibitors
Linhong He, Mingfeng Shao, Taijin Wang, et al.
Acta Oncologica (Stockholm, Sweden)
|
June 28, 2023
Tumor-infiltrating lymphocytes predict efficacy of immunotherapy in advanced non-small cell lung cancer: a single-center retrospective cohort study
Wenjie Zhang, Sumei Li, Chufeng Zhang, et al.
Advanced Biology
|
February 23, 2026
Feiwei Mixture Exerts Antitumor Activity Against Non-Small Cell Lung Cancer via Regulating NR1D1-Mediated Immune Cell Infiltration
Haiyong Wang, Lingsun Guo, Yu Zhao, et al.
Archiv Der Pharmazie
|
September 26, 2017
Design and Synthesis of a Highly Selective JAK3 Inhibitor for the Treatment of Rheumatoid Arthritis
Linhong He, Heying Pei, Tingxuan Lan, et al.
The Journal of Chemical Physics
|
April 8, 2025
Light-matter interaction at the nano- and molecular scale
Kaifeng Wu, Chufeng Zhang, Xinfeng Liu, et al.
Technology in Cancer Research & Treatment
|
May 8, 2015
Progress of Circulating Tumor Cells in Cancer Management
Chufeng Zhang, Lijie Wang, Yan Guan, et al.
Journal of Cancer Research and Clinical Oncology
|
January 27, 2024
Efficacy of immunotherapy in HER2-mutated non-small cell lung cancer: a single-arm meta-analysis
Juguang Zhang, Weizhong Han, Jun Guo, et al.
Oncology Letters
|
April 8, 2024
Efficacy and survival outcomes of alectinib vs. crizotinib in ALK‑positive NSCLC patients with CNS metastases: A retrospective study
Qing Liu, Ying Fu, Jun Guo, et al.
European Journal of Medicinal Chemistry
|
March 16, 2019
Design, synthesis and evaluation of novel 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as potent, selective and reversible Bruton's tyrosine kinase (BTK) inhibitors for the treatment of rheumatoid arthritis
Chufeng Zhang, Heying Pei, Jun He, et al.
Page
of 5